Tag:
antibiotics
Latest Headlines
Latest Headlines
Rib-X Pharma delays IPO after price halved
Before postponing the IPO, Rib-X was aiming to raise $65 million in the offering.
PolyMedix shares slide on report of positive Phase II antibiotic data
PolyMedix is touting positive topline data from the mid-stage study of its lead antibiotic today, but the news couldn't keep its share price from sliding.
Chinese regulators freeze sales of drugs with toxic capsules
The country's drug watchdog has banned the sale of 13 drugs that are made with capsules containing toxic levels of chromium.
FDA to require prescriptions for farm antibiotics
The FDA will require farmers to get prescriptions for livestock antibiotics under new rules designed to curb development of antibiotic-resistant pathogens.
'Animal rule' allowed for J&J drug backed for new approval
FDA advisors have backed approval for Levaquin for a new use that the federal government had pushed for.
Judge: FDA must follow up on farm antibiotics ban
A federal judge has ordered the agency to disapprove two antibiotics often used on farms.
Durata, with license to Pfizer drug, lays plans for $86M IPO
Venture-backed Durata Therapeutics has filed paperwork for an $86 million initial public offering.
FDA nudged to treat antibiotics like rare disease drugs
A research group wants the FDA to give applications for new antibiotics some of the same treatment now lavished on rare disease drugs.
Combo drug offers potent weapon against radiation exposure
In the horrific event of a nuclear disaster, people exposed to radiation would have few treatment options. Yet researchers from Harvard-affiliated hospitals have found that a combo drug could give
AvidBiotics' protein treatment could fight foodborne bacteria, study shows
E.coli--a nasty bacteria contracted from contaminated foods like ground meat or produce--may have a new foe: A novel antibacterial protein. The orally administered Avidocin protein, developed by
